| Navin Fluorine: Steep Correction due to resignation of MD is opportunity to buy for target price of Rs 5368 (40% upside) | |
| Company: | Navin Fluorine |
| Brokerage: | HDFC Sec |
| Date of report: | October 5, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 40% |
| Summary: | We expect NFIL’s PAT to grow at a 30% CAGR over FY23-26E, led by a 33% CAGR in EBITDA. We retain our BUY rating on Navin Fluorine, with a target price of INR 5,368 (WACC 11%, terminal growth 5.5%) on the back of (1) earning visibility given long-term contracts in speciality chemicals and HPP segments; (2) a tilt in sales mix towards high margin high-value business; and (3) capacity expansion-led growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HDFC Sec, Navin Fluorine |
| APL Apollo Tubes: Raipur Plant will boost margins through innovative product offerings. Buy for target price of Rs 1930: Motilal Oswal | |
| Company: | APL Apollo Tubes |
| Brokerage: | Motilal Oswal |
| Date of report: | October 3, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 18% |
| Summary: | The Raipur plant will manufacture only value-added products (VAP), which will drive up the overall margin profile for the company. Additionally, these plants will |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | APL Apollo Tubes, Motilal Oswal |
| Mayur Uniquoters is a conviction idea in small cap auto ancillary space for 30% upside potential: ICICI Direct | |
| Company: | Mayur Uniquoters |
| Brokerage: | ICICI-Direct |
| Date of report: | October 5, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 30% |
| Summary: | We assign BUY rating on Mayur Uniquoters amidst healthy growth prospects especially in auto OEM export space, healthy margin profile (~20%), capital efficient business model (RoIC: 20%+) & Cash positive B/S (Net cash at ~₹180 crore as of FY23) |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI-Direct, Mayur Uniquoters |
| NIFTY Dec’23 Target is 20,200. Top 16 stock picks to buy for up to 31% upside: Axis Securities | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | October 7, 2023 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 31% |
| Summary: | The Indian economy stands at a sweet spot of growth and remains the land of stability against the backdrop of a volatile global economy. We continue to believe in its long-term growth story, supported by the emerging favourable structure as increasing Capex enables banks to improve credit growth. Strong earnings trajectory continues in the NIFTY 50 universe. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Buy MCX for target price of Rs 2400 (26% upside). Tech transition is underway; options surge: HDFC Sec | |
| Company: | MCX |
| Brokerage: | HDFC Sec |
| Date of report: | September 27, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | The Multi Commodity Exchange of India Ltd (MCX) has witnessed impressive growth in options volume but uncertainty around the technology shift has been the key overhang. The commodity exchange, in a press release, has indicated that the technology shift is underway and might happen three months ahead of the deadline. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HDFC Sec, MCX |
| Review of 12 Speciality Chemicals stocks with Buy, Hold & Reduce Recommendations by ICICI Securities | |
| Company: | Speciality Chemicals stocks |
| Brokerage: | ICICI Securities |
| Date of report: | September 22, 2023 |
| Type of Report: | Sector Report |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Speciality Chemicals, Chemical prices for Jul’23 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI Securities, Speciality Chemicals |
| Senco Gold ‘Gold’en opportunity – At a bargain; initiate with BUY: Emkay | |
| Company: | Senco Gold |
| Brokerage: | Emkay |
| Date of report: | September 20, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 33.1% |
| Summary: | Senco Gold boasts of being one of the top-2 as regards revenue share in the ~Rs800bn eastern market, abetted by strongest brand accessibility vs peers, in terms of product, price & penetration |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Emkay, Senco Gold |
| Buy PNC Infratech for target price of Rs 460. Asset monetisation – a key trigger ahead: ICICI Direct | |
| Company: | PNC Infratech |
| Brokerage: | ICICI-Direct |
| Date of report: | September 22, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 25% |
| Summary: | PNC Infratech has established itself as a strong executor in roads and water infra segments. Additionally, superior execution capabilities via ownership of modern |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI-Direct, PNC Infratech |
| JB Chem is the preferred pick due to aggressive growth focus & high return ratios: Nirmal Bang | |
| Company: | J.B. Chemicals & Pharmaceuticals Ltd |
| Brokerage: | Nirmal Bang |
| Date of report: | September 15, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 16% |
| Summary: | JB Pharma remains our preferred pick, mainly underpinned by aggressive growth focus in the Domestic+CDMO business, high return ratios, lean B/S and healthy FCF |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | J.B. Chemicals & Pharmaceuticals Ltd, Nirmal Bang |
| KEC International is on the cusp of a major turnaround driven by stellar growth. Buy for target price of Rs 816: Yes Securities | |
| Company: | KEC International |
| Brokerage: | Yes Securities |
| Date of report: | August 31, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 21% |
| Summary: | The company is on the cusp of a major turnaround driven by stellar growth in its TAM, sequential margin recovery, and reduction of working capital to normalized levels |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | KEC International, Yes Securities |